IP Library Patent Application 14848043
Patent Application
App. No. 14/848,043

SEMI-SOLID CHEWABLE DOSAGE FORM FOR OVER-THE-COUNTER MEDICATIONS AND METHOD FOR PRODUCING SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/848,043
Abstract

The invention provides a semi-solid chewable dosage form for use as an over-the-counter medication that contains an active pharmaceutical ingredient to treat symptoms associated with allergies, colds, coughs, fever, pain, gastrointestinal disorders, sleep, and other common conditions. The invention further provides a semi-solid chewable dosage form that contains an active pharmaceutical ingredient, a gelling agent, gelatin, sugar, a polyol, and a pH adjusting agent. The invention also provides a semi-solid chewable dosage form that contains a gelling agent, sugar, a polyol, glycerin, and a pH adjusting agent.

Claims (37)

1 . A semi-solid chewable dosage form comprising an active pharmaceutical ingredient, a gelling agent, gelatin, sugar, a polyol, and a pH adjusting agent.

2 . The semi-solid chewable dosage form of claim 1 , wherein the gelling agent is pectin, the gelatin is hydrolyzed gelatin, and the polyol is hydrolyzed starch hydrolysate.

3 . The semi-solid dosage form of claim 2 , wherein pectin is present in an amount from about 0.5% by weight to about 7% by weight, hydrolyzed gelatin is present in an amount from about 0.5% by weight to about 8% by weight, and hydrolyzed starch hydrolysate is present in an amount from about 40% by weight to about 90% by weight.

4 . The semi-solid chewable dosage form of claim 1 , wherein the active pharmaceutical ingredient is diphenhydramine hydrochloride.

5 . The semi-solid chewable dosage form of claim 4 , wherein the gelling agent is pectin.

6 . The semi-solid chewable dosage form of claim 4 , wherein the gelatin is hydrolyzed gelatin.

7 . The semi-solid chewable dosage form of claim 4 , wherein the polyol is hydrolyzed starch hydrolysate.

8 . The semi-solid dosage form of claim 4 , wherein the gelling agent is pectin present in an amount from about 0.5% by weight to about 7% by weight, the gelatin is hydrolyzed gelatin present in an amount from about 0.5% by weight to about 8% by weight, and the polyol is hydrolyzed starch hydrolysate present in an amount from about 40% by weight to about 90% by weight.

9 . A semi-solid chewable dosage form comprising:

an active pharmaceutical ingredient;

pectin in an amount from about 0.5% by weight to about 7% by weight;

sugar in an amount from about 40% by weight to about 95% by weight;

hydrolyzed starch hydrolysate in an amount from about 40% by weight to about 90% by weight;

hydrolyzed gelatin in an amount from about 0.5% by weight to about 8% by weight;

sodium citrate in an amount from about 0.1% by weight to about 1% by weight; and

citric acid in an amount from about 0.5% by weight to about 3% by weight;

wherein the water content of the semi-solid dosage form is from about 8% by weight to about 15% by weight.

10 . The semi-solid chewable dosage form of claim 9 , wherein the active pharmaceutical ingredient is diphenhydramine hydrochloride.

11 . The semi-solid dosage form of claim 9 , wherein pectin is present in an amount from about 1% by weight to about 5% by weight, hydrolyzed gelatin is present in an amount from about 1% by weight to about 5% by weight, and the hydrolyzed starch hydrolysate present in an amount from about 40% by weight to about 60% by weight.

12 . A semi-solid chewable dosage form comprising an active pharmaceutical ingredient, a gelling agent, sugar, a polyol, glycerin, and a pH adjusting agent.

13 . The semi-solid chewable dosage form of claim 12 , wherein the gelling agent is pectin and the polyol is hydrolyzed starch hydrolysate.

14 . The semi-solid dosage form of claim 13 , wherein pectin is present in an amount from about 0.5% by weight to about 7% by weight, hydrolyzed starch hydrolysate present in an amount from about 40% by weight to about 90% by weight, and glycerin is present in an amount from about 0.5% by weight to about 5% by weight.

15 . The semi-solid chewable dosage form of claim 12 , wherein the active pharmaceutical ingredient is loratadine.

16 . The semi-solid chewable dosage form of claim 15 , wherein the gelling agent is pectin.

17 . The semi-solid chewable dosage form of claim 15 , wherein the gelatin is hydrolyzed gelatin.

18 . The semi-solid chewable dosage form of claim 15 , wherein the polyol is hydrolyzed starch hydrolysate.

19 . The semi-solid dosage form of claim 15 , wherein the gelling agent is pectin present in an amount from about 0.5% by weight to about 7% by weight, the polyol is hydrolyzed starch hydrolysate present in an amount from about 40% by weight to about 90% by weight, and glycerin is present in an amount from about 0.5% by weight to about 5% by weight.

20 . A semi-solid chewable dosage form comprising:

an active pharmaceutical ingredient;

pectin in an amount from about 0.5% by weight to about 7% by weight;

sugar in an amount from about 40% by weight to about 95% by weight;

hydrolyzed starch hydrolysate in an amount from about 40% by weight to about 90% by weight;

glycerin in an amount from about 0.5% by weight to about 5% by weight;

sodium citrate in an amount from about 0.1% by weight to about 1% by weight; and

citric acid in an amount from about 0.5% by weight to about 3% by weight;

wherein the water content of the semi-solid dosage form is from about 8% by weight to about 15% by weight.

21 . The semi-solid chewable dosage form of claim 20 , wherein the active pharmaceutical ingredient is loratadine.

Assignments (5)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 44425/0263 Recorded Dec 16, 2019
From: ADAMS STREET CREDIT ADVISORS LP, AS ADMINISTRATIVE AGENT
To: SANTA CRUZ PHARMACEUTICALS, INC.
Reel/Frame 051317/0878 →
SECURITY INTEREST Recorded Dec 18, 2017
From: SANTA CRUZ PHARMACEUTICALS, INC.; BESTCO LLC
To: ADAMS STREET CREDIT ADVISORS LP, AS ADMINISTRATIVE AGENT
Reel/Frame 044425/0263 →
SECURITY INTEREST Recorded Dec 15, 2017
From: SANTA CRUZ PHARMACEUTICALS, INC.; BESTCO LLC
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 044405/0218 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2015
From: WESTHUSING, MICHAEL T.; BAI, YONG; MEDRI, MARIO W.
To: SANTA CRUZ PHARMACEUTICALS, INC.
Reel/Frame 036588/0176 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2015
From: WESTHUSING, MICHAEL T.; BAI, YONG; MEDRI, MARIO W.
To: SANTA CRUZ PHARMACEUTICALS, INC.
Reel/Frame 036627/0941 →